Second national serum bank for population-based seroprevalence studies in the Netherlands.
about
The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseasesAn evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005-2011.Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virusAge-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgGImmunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccinePrevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported casesPrevalence of livestock-associated MRSA in communities with high pig-densities in The Netherlands.Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagersParticipation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires.Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands.Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks.Human hantavirus infections in the NetherlandsCharacteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclassesImproved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoidTowards an integrated approach in surveillance of vector-borne diseases in EuropeDynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections.Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination.Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006.Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalencePrimary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines.
P2860
Q26824389-88F64637-A7F0-4E93-BEF6-04BF18AC43E2Q27312422-72E1FA86-7B62-42BE-B821-FE9461D6E1D9Q28397298-9E2F6419-4DBA-4FBC-965A-A4C4B667B039Q28741100-D582B4F0-DF1F-49C2-B471-B0A32A56E191Q28749695-6F1F6EF0-9A64-41F0-8368-D514A30D25E8Q30398281-21C22812-0D0B-4BCB-A2A8-FCAD8DDD7CDBQ30416214-167873F2-1A91-42CF-9E1F-C607F5F038A4Q31074194-67804623-3FE7-452A-9392-4E51455ED8DFQ33535945-ECB98724-BBFA-487C-80B3-15FF58A92F42Q33705199-E73579B1-64BF-4103-A951-6813CFB3B62DQ33769972-C0816948-9596-4508-AFC6-292382C92A09Q33806774-E147EBD3-8766-437D-BB57-1707C5045051Q34134609-6E73BD20-6A4C-4D8B-B90D-B3F8CD4AE068Q34153704-2929BF02-7FED-4C94-B9A3-A3A1CF00B414Q34477498-1C6E5BD0-71C1-44E6-9D60-36BF6E18CD2BQ34631767-0B1B21EC-6C45-428F-85DB-CBDDE93B3FEDQ34641552-957C0CF5-F8D7-4E00-A89C-6C167DFCAF5DQ34994905-A464464F-CA05-4BEE-87E0-84D79F4B853AQ35138647-0EBF2B2B-552A-404B-B503-D822495861ECQ35420447-9ADEC6F3-2FDD-4322-BE47-DE92B7A42FABQ35900565-B1165B71-68C1-461F-8E4C-824DFE259C91Q35915484-A62A6DAF-969D-49D8-A3CD-CFC12ADB6C02Q35919738-23A05E69-3A25-4A95-B55A-CFFEB98411F9Q36092857-026E285C-6D88-443C-88BB-C325BAD1506EQ37124678-61BCE537-A264-4E2D-A4AF-7AF6D21FAD94Q37296094-2F306A2B-CD57-4891-9C8A-0AC8CC107689Q38791439-4DFF02E4-1637-4642-ACCF-47DD8D34E4F7Q41929983-70E5A864-0E7F-4301-B386-4832B583B7D2Q47558906-DEB08D9B-8E76-4E78-831C-822A9B656F5DQ55114818-191A2E1C-6F58-4F70-A99D-2602024FD75E
P2860
Second national serum bank for population-based seroprevalence studies in the Netherlands.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Second national serum bank for ...... ce studies in the Netherlands.
@ast
Second national serum bank for ...... ce studies in the Netherlands.
@en
type
label
Second national serum bank for ...... ce studies in the Netherlands.
@ast
Second national serum bank for ...... ce studies in the Netherlands.
@en
prefLabel
Second national serum bank for ...... ce studies in the Netherlands.
@ast
Second national serum bank for ...... ce studies in the Netherlands.
@en
P2093
P1476
Second national serum bank for ...... ce studies in the Netherlands.
@en
P2093
Berbers GA
Coutinho RA
de Melker HE
van der Klis FR
P304
P577
2009-07-01T00:00:00Z